OpenSourceMalaria:GSK Arylpyrrole Series: Difference between revisions
No edit summary |
No edit summary |
||
Line 37: | Line 37: | ||
Proposed Resynthesis Strategy:<br> | Proposed Resynthesis Strategy:<br> | ||
[[Image: | [[Image:arylpyrrolesynth.png|none|600px|left|Proposed Strategy]]<br> |
Revision as of 23:06, 15 August 2011
This series has the general structure:
These compounds are currently under study by the Todd lab at the University of Sydney and the Medicines for Malaria Venture, Geneva. As an open source project, anyone may participate:
Coordination/Discussion site:
Electronic Lab Notebooks:
Feeds:
Known series examples:
TCMDC 123812
InChI=1/C15H15FN2O3/c1-9-7-13(15(20)21-8-14(17)19)10(2)18(9)12-5-3-11(16)4-6-12/h3-7H,8H2,1-2H3,(H2,17,19)
SMILES: O=C(N)COC(=O)c2c(n(c1ccc(F)cc1)c(c2)C)C
CAS Registry Number: 733026-12-5
Chemspider page
ChEMBL Page
Resynthesis:
TCMDC 123794
InChI=1/C26H25FN4O4/c1-16-14-22(17(2)30(16)20-12-10-19(27)11-13-20)26(34)35-15-23(32)28-24-18(3)29(4)31(25(24)33)21-8-6-5-7-9-21/h5-14H,15H2,1-4H3,(H,28,32)
SMILES: Fc1ccc(cc1)n2c(cc(c2C)C(=O)OCC(=O)NC=4C(=O)N(c3ccccc3)N(C=4C)C)C
Chemspider page
ChEMBL Page
Resynthesis:
Proposed Resynthesis Strategy: